X0306 4 2022-06-27 0 0001434316 FATE THERAPEUTICS INC FATE 0001934232 Powl Brian T. C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 0 1 0 0 Chief Commercial Officer Common Stock 2022-06-27 4 A 0 45000 0.00 A 45000 D Stock Option (Right to Buy) 26.25 2022-06-27 4 A 0 70000 0.00 A 2032-06-27 Common Stock 70000 70000 D Exempt grant of restricted stock units pursuant to the Issuer's Amended and Restated Inducement Equity Plan. 25% of the award will vest on July 1, 2023, and 25% of the remainder shall vest on July 1, 2024, July 1, 2025, and July 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date. The option shall vest as to 25% of the underlying shares on June 27, 2023 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date. /s/ Cindy Tahl, as Attorney-in-Fact 2022-06-29